13FPulse
中
BT

BTMD BIOTE CORP -A

2026Q1 · CUSIP 090683103 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
83
Δ holders QoQ
-2
Breadth percentile
Top 70%
Whale holders
49
Δ whales
+1
Inst. holding value
$20M
New positions
18
Closed positions
20
Price momentum (1Q)
—
Put / Call
0/0

Breadth history (34 quarters)

2022Q2: holders=13 2022Q3: holders=17 2022Q4: holders=17 2023Q1: holders=28 2023Q2: holders=56 2023Q3: holders=56 2023Q4: holders=55 2024Q1: holders=55 2024Q2: holders=76 2024Q3: holders=84 2024Q4: holders=96 2025Q1: holders=91 2025Q2: holders=98 2025Q3: holders=87 2025Q4: holders=85 2026Q1: holders=83 -28 -14 +0 +14 +28 1157103 22Q222Q423Q223Q424Q224Q425Q225Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2024Q2 Top 12% +13.5% -15.4%
2023Q2 Top 7% -3.5% -9.9%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
5.7
EPS (TTM)
$0.43
EPS YoY
-25.9%
Revenue (TTM)
$0.2B
Revenue YoY
-5.6%
Net margin
8.3%
ROE
—
Debt ratio
—
FCF (TTM)
$29M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
2023-03-31: EPS -0.39 2023-06-30: EPS -0.25 2023-09-30: EPS 0.24 2023-12-31: EPS 0.53 2024-03-31: EPS -0.12 2024-06-30: EPS -0.21 2024-09-30: EPS 0.33 2024-12-31: EPS 0.09 2025-03-31: EPS 0.37 2025-06-30: EPS 0.10 2025-09-30: EPS 0.22 2025-12-31: EPS 0.05 2026-03-31: EPS 0.06 0M 26M 51M $M -0.43 0.08 0.58 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 10 3 28 53 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)

Get the next update

2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.